KNSA: Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares Company Profile & Statistics

About

Kiniksa Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa Pharmaceuticals Ltd. is based in Massachusetts, United States.

Info & Links

CEO

Sanj K. Patel

Headquarters

23 Old Bond Street, Floor 3
London, X0 WIS 4PZ, UNITED KINGDOM

Auditor

PricewaterhouseCoopers LLP

Share holders

Employees

315

Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares Statistics

Valuation Measures

Market Capitalization²

1.47B

Enterprise Value

1.28B

Enterprise Value/EBITDA(ttm)

-29.25

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

3.70

Price to Book(mrq)

3.25

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

85.72%

Operating Margin(ttm)

-8.30%

Profit Margin(ttm)

-11.08%

Return on Equity(ttm)

-7.31%

Return on Invested Capital(ttm)

-9.93%

Return on Assets(ttm)

-5.95%

Income Statement

Revenue(ttm)

423.24M

Revenue Per Share(ttm)

5.83

Gross Profit(ttm)

362.33M

EBITDA(ttm)³

-43.92M

Net Income Available to Common(ttm)

-43.19M

Diluted EPS(ttm)

-0.14

Share Statistics

Beta (5Y Monthly)

0.32

52-Week Change

19.23%

S&P 500 52-Week Change

6.35%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

72.64M

Dividend Yield

0.00%

Float⁴

32.80M

% Held by Insiders

54.57%

% Held by Institutions

53.95%

Balance Sheet

Total Cash(mrq)

243.63M

Total Cash Per Share(mrq)

3.35

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.30%

Quick Ratio(mrq)

2.95%

Book Value Per Share(mrq)

6.05

Cash Flow

Operating Cash Flow Per Share(ytd)

0.36

Free Cash Flow(ytd)

25.44M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

KNSA

Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares

Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares Profile